<DOC>
	<DOCNO>NCT02647944</DOCNO>
	<brief_summary>Obesity associate difference stomach function , feel fullness meal , total calorie consume buffet meal . Based upon previous research , study hypothesis weight loss pharmacological agent may individualize , base abnormality gastrointestinal function . These study provide support principle specific obesity medication select accord individual characteristic , anticipate approach enhance efficacy medication treatment obesity .</brief_summary>
	<brief_title>Pilot Study Effect Liraglutide Weight Loss Gastric Functions Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Overweight obese adult ( ≥30 kg/m2 ≥27 kg/m2 obesityrelated comorbidity ) . Subjects reside within 125 mile Mayo Clinic Rochester , Minnesota . Healthy individual unstable psychiatric disease currently treatment cardiac , pulmonary , gastrointestinal , hepatic , renal , hematological , neurological , endocrine ( hyperglycemia type 2 diabetes mellitus metformin ) disorder . Women childbearing potential use effective form contraception , negative pregnancy test within 48 hour enrolment radiation exposure . Subjects must ability provide informed consent trialrelated activity . Exclusion criterion : Weight exceed 137 kilogram ( safety limit camera measure gastric volume ) . Abdominal surgery appendectomy , Caesarian section tubal ligation . Positive history chronic gastrointestinal disease , systemic disease could affect gastrointestinal motility , use medication may alter gastrointestinal motility , appetite absorption , e.g. , orlistat . Patients personal family history medullary thyroid carcinoma Multiple Endocrine Neoplasiatype 2 . Patients personal history pancreatitis ( acute chronic ) Significant untreated psychiatric dysfunction base upon screen Hospital Anxiety Depression Inventory , selfadministered alcoholism screen test ( AUDITC ) , Questionnaire Eating Weight Patterns ( binge eat disorder bulimia ) . If dysfunction identify Hospital Anxiety Depression ( HAD ) score &gt; 8 difficulty substance eat disorder , participant exclude give referral letter his/her primary care doctor appraisal followup . Intake medication , whether prescribe counter ( except multivitamin ) , within 7 day study . Exceptions birth control pill , estrogen replacement therapy , thyroxin replacement therapy medication administer comorbidities long alter gastrointestinal motility include gastric emptying ( GE ) gastric accommodation . For example , statins hyperlipidemia , diuretic , βadrenergic blocker , Angiotensin Converting Enzyme ( ACE ) inhibitor angiotensin antagonist hypertension , metformin type 2 diabetes mellitus prediabetes permissible . In contrast , resin sequestrants hyperlipidemia [ may reduce GE reduce appetite , α2adrenergic agonist hypertension , GLP1 receptor agonist ( exenatide ) amylin analog ( pramlintide ) permissible significantly affect GE and/or gastric accommodation . Hypersensitivity study medication , liraglutide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>